Patent Agent
Veronica Singh, Ph.D., combines experience in patent prosecution and technology commercialization with an advanced scientific background in pharmacology, molecular biology, and preclinical research. Her technical expertise spans translational medicine, medical devices, and artificial intelligence (AI)-enabled biomedical technologies.
As a former patent and licensing intern for a statewide research and innovation organization, Veronica has extensive experience performing intellectual property (IP) due diligence and assisting with the development of patent strategies for technologies spanning RNA therapeutics, medical devices, implants, wireless power systems, and AI-enabled diagnostics. She also supports the preparation, filing, and prosecution of patent applications before the U.S. Patent and Trademark Office (USPTO). In her role, Veronica conducted inventor interviews, evaluated patentability, and performed prior art and market research to support both patent protection and licensing initiatives. Her legal training includes focused instruction in patent preparation and prosecution, claim drafting, infringement analysis, and patent litigation through a competitive IP program for scientists and engineers. This experience enables her to assess innovations from both technical and commercial perspectives and to communicate complex scientific concepts clearly to inventors, attorneys, and other stakeholders.
Veronica earned a doctorate in pharmacology at the State University of New York Upstate Medical University, where she led multidisciplinary, cross-institutional research using molecular, cellular, in vivo, and computational approaches to characterize and establish a novel preclinical model of a genetic disorder associated with neurocardiac electrical disturbances. She gained technical experience with ion-channel disorders, electrophysiology, molecular biology, protein chemistry, pharmacological assays, large-animal models, physiological monitoring, and advanced statistical and survival analyses. As an undergraduate research fellow at the State University of New York at Oswego, Veronica was awarded the Summer Scholars Challenge Grant to investigate protein interactions crucial for the activation and regulation of the innate immune system, including quantification of the expression of Complement Component 2 in Pichia Pastoris and E. Coli expression systems.
Veronica authored and coauthored peer-reviewed research concerning cardiac arrhythmia, epilepsy, potassium channelopathies, neurocardiac disease, and long-term electroencephalogram (EEG) and electrocardiogram (ECG) monitoring, as well as presented her work at national scientific meetings.
Lead author. “Knock-in Kcnh2 rabbit model of long QT syndrome type-2, epilepsy, and sudden death,” Journal of Translational Medicine, 2025.
Coauthor. “Surgical Implant Procedure and Wiring Configuration for Continuous Long-Term EEG/ECG Monitoring in Rabbits,” JoVE, 2025.
Lead author. “Neurocardiac pathologies associated with potassium channelopathies,” Epilepsia, 2024.
Lead author. “It is premature for a unified hypothesis of sudden unexpected death in epilepsy: A great amount of research is still needed to understand the multisystem cascade,” Epilepsia, 2023.
Member, Phi Kappa Phi, 2019.
Recipient, Summer Scholars Challenge Grant for undergraduate research, 2017 & 2018.
summa cum laude, 2019
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.